Most Active InvestorsFind investorsBlogPricing
Start for free
Start for free
Cambrian Biopharma logo

Cambrian Biopharma

North America, New York, United States, New York

Description

Cambrian is a distributed development company building therapeutics to lengthen health span.

Investor Profile

Cambrian Biopharma has backed more than 8 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 63% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Life Science, Medical.

Stage Focus

  • Series A (38%)
  • Seed (25%)
  • Series B (25%)
  • Series C (13%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Medical
  • Therapeutics
  • Biopharma
  • Health Care
  • Pharmaceutical
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cambrian Biopharma frequently co-invest with?

CaaS Capital Management
CaaS Capital Management
North America, New York, United States, New York
Co-Investments: 1
Future Ventures
Future Ventures
North America, California, United States, San Francisco
Co-Investments: 3
Adage Capital Management
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
New Enterprise Associates
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 1
LG Technology Ventures
LG Technology Ventures
North America, California, United States, Santa Clara
Co-Investments: 1
Clough Capital Partners
Clough Capital Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
CAM Capital
CAM Capital
North America, New York, United States, New York
Co-Investments: 1
Asymmetry Ventures
Asymmetry Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Presight Capital
Presight Capital
North America, California, United States, West Hollywood
Co-Investments: 2
Apeiron Investment Group
Apeiron Investment Group
Europe, NA - Malta, Malta, Sliema
Co-Investments: 2

Which angels does Cambrian Biopharma often collaborate with?

BB
Bruce Barclay
North America, California, United States
Shared Deals: 1
KW
Kent Wakeford
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Cambrian Biopharma?

Amplifier Therapeutics

New York, New York, United States

Amplifier Therapeutics is a biopharmaceutical firm, developing AMP-activated protein kinase (AMPK) activator molecules.

BiopharmaBiotechnologyLife Science
Series AOct 17, 2023
Amount Raised: $33,250,000
Vita Therapeutics

Baltimore, Maryland, United States

Vita Therapeutics is a cell engineering company that develops life-transformative treatments.

BiotechnologyMedicalTherapeutics
Series BOct 12, 2022
Amount Raised: $31,000,000
Oviva Therapeutics

New York, New York, United States

Oviva Therapeutics is a movement to improve women's experience of aging through biomedical research, development and advocacy.

BiotechnologyHealth Care
SeedMay 19, 2022
Amount Raised: $11,500,000
Vita Therapeutics

Baltimore, Maryland, United States

Vita Therapeutics is a cell engineering company that develops life-transformative treatments.

BiotechnologyMedicalTherapeutics
Series AJun 23, 2021
Amount Raised: $32,000,000
Arcellx

Gaithersburg, Maryland, United States

Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.

BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical
Series CApr 13, 2021
Amount Raised: $115,000,000
Sensei Biotherapeutics

Gaithersburg, Maryland, United States

Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.

BiotechnologyHealth DiagnosticsLife ScienceMedicalTherapeutics
Series BJan 11, 2021
Amount Raised: $30,000,000
Sensei Biotherapeutics

Gaithersburg, Maryland, United States

Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.

BiotechnologyHealth DiagnosticsLife ScienceMedicalTherapeutics
Series AOct 7, 2020
Amount Raised: $28,500,000
Samsara Therapeutics

Boston, Massachusetts, United States

Samsara Therapeutics is a biopharmaceutical company that aims to discover therapeutics to treat rare genetic and neurodegenerative disease.

BiopharmaBiotechnologyLife SciencePharmaceutical
SeedDec 20, 2019
Amount Raised: $3,200,000

Find More Investors Like Cambrian Biopharma

Discover similar investors in our database and build your perfect investor list.

series_a InvestorsInvestors in New YorkBrowse All InvestorsTop Investors

Need help with your fundraising strategy?Read our fundraising guides

Decorative background shape
Decorative background shape

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator

Investors By Location

San FranciscoNew York CityBostonLos AngelesChicagoLondonParisIndiaSingaporeTel Aviv

Investors By Stage

Angel InvestorsPre-Seed InvestorsSeed InvestorsSeries A InvestorsSeries B InvestorsSeries C InvestorsSeries D Investors
Cambrian Biopharma | Pipeseed